1. Home
  2. NMRA vs ARQ Comparison

NMRA vs ARQ Comparison

Compare NMRA & ARQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • ARQ
  • Stock Information
  • Founded
  • NMRA 2019
  • ARQ 1996
  • Country
  • NMRA United States
  • ARQ United States
  • Employees
  • NMRA N/A
  • ARQ N/A
  • Industry
  • NMRA
  • ARQ
  • Sector
  • NMRA
  • ARQ
  • Exchange
  • NMRA Nasdaq
  • ARQ NYSE
  • Market Cap
  • NMRA 287.6M
  • ARQ 208.8M
  • IPO Year
  • NMRA 2023
  • ARQ N/A
  • Fundamental
  • Price
  • NMRA $1.16
  • ARQ $4.73
  • Analyst Decision
  • NMRA Buy
  • ARQ Strong Buy
  • Analyst Count
  • NMRA 8
  • ARQ 1
  • Target Price
  • NMRA $10.14
  • ARQ $9.00
  • AVG Volume (30 Days)
  • NMRA 1.4M
  • ARQ 290.6K
  • Earning Date
  • NMRA 03-03-2025
  • ARQ 03-05-2025
  • Dividend Yield
  • NMRA N/A
  • ARQ N/A
  • EPS Growth
  • NMRA N/A
  • ARQ N/A
  • EPS
  • NMRA N/A
  • ARQ N/A
  • Revenue
  • NMRA N/A
  • ARQ $108,959,000.00
  • Revenue This Year
  • NMRA N/A
  • ARQ $32.45
  • Revenue Next Year
  • NMRA N/A
  • ARQ $16.18
  • P/E Ratio
  • NMRA N/A
  • ARQ N/A
  • Revenue Growth
  • NMRA N/A
  • ARQ 9.86
  • 52 Week Low
  • NMRA $1.14
  • ARQ $4.01
  • 52 Week High
  • NMRA $17.19
  • ARQ $8.26
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 24.42
  • ARQ 35.01
  • Support Level
  • NMRA $1.26
  • ARQ $4.83
  • Resistance Level
  • NMRA $1.48
  • ARQ $5.28
  • Average True Range (ATR)
  • NMRA 0.13
  • ARQ 0.30
  • MACD
  • NMRA 0.06
  • ARQ 0.02
  • Stochastic Oscillator
  • NMRA 5.77
  • ARQ 52.94

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About ARQ ARQ INC

Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.

Share on Social Networks: